The five-year grant from the National Institutes of Health will allow researchers to sequence the DNA of 1,400 samples from sarcoidosis patients and their families, comparing them to a targeted genetic analysis of another 1,000 samples and searching for related genes among the two groups. Once the related genes are identified, researchers will look at the proteins they create for a possible therapeutic agent to fight sarcoidosis.
Related Articles on Pain Management:
Medical Schools Neglect Pain Management Teachings, Study Says
Budget Cuts Threaten California’s Drug Monitoring System
Illinois Pain Physician Discusses Co-Owning Clinic With Wife
